1. Home
  2. CL vs ZTS Comparison

CL vs ZTS Comparison

Compare CL & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colgate-Palmolive Company

CL

Colgate-Palmolive Company

HOLD

Current Price

$79.77

Market Cap

64.0B

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$126.15

Market Cap

53.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CL
ZTS
Founded
1806
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.0B
53.9B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CL
ZTS
Price
$79.77
$126.15
Analyst Decision
Buy
Buy
Analyst Count
16
11
Target Price
$90.47
$174.60
AVG Volume (30 Days)
6.0M
6.1M
Earning Date
01-30-2026
02-12-2026
Dividend Yield
2.61%
1.68%
EPS Growth
2.56
11.64
EPS
3.57
5.94
Revenue
$20,097,000,000.00
$9,397,000,000.00
Revenue This Year
$3.88
$3.04
Revenue Next Year
$3.33
$4.98
P/E Ratio
$22.33
$21.26
Revenue Growth
N/A
2.68
52 Week Low
$74.55
$115.25
52 Week High
$100.18
$177.40

Technical Indicators

Market Signals
Indicator
CL
ZTS
Relative Strength Index (RSI) 54.40 57.01
Support Level $77.77 $121.12
Resistance Level $80.40 $125.53
Average True Range (ATR) 1.30 2.71
MACD 0.20 1.15
Stochastic Oscillator 85.82 99.67

Price Performance

Historical Comparison
CL
ZTS

About CL Colgate-Palmolive Company

Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: